{"id":"https://openalex.org/W4416636154","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4769","title":"Late Breaking Abstract - Sustained suppression of type 2 inflammatory biomarkers in asthma with APG808, a half-life extended anti-IL-4R\u03b1 monoclonal antibody","display_name":"Late Breaking Abstract - Sustained suppression of type 2 inflammatory biomarkers in asthma with APG808, a half-life extended anti-IL-4R\u03b1 monoclonal antibody","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416636154","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4769"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa4769","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4769","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4769","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016828717","display_name":"Amol P. Kamboj","orcid":"https://orcid.org/0000-0003-3611-7326","observed_orcids":["https://orcid.org/0000-0003-3611-7326"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amol Kamboj","raw_affiliation_strings":["1Apogee Therapeutics, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apogee Therapeutics, Waltham, MA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lauren Wood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren Wood","raw_affiliation_strings":["1Apogee Therapeutics, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apogee Therapeutics, Waltham, MA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cecilia Hale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecilia Hale","raw_affiliation_strings":["1Apogee Therapeutics, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apogee Therapeutics, Waltham, MA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015826586","display_name":"David A. Plotnik","orcid":"https://orcid.org/0000-0003-0688-8613","observed_orcids":["https://orcid.org/0000-0003-0688-8613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Plotnik","raw_affiliation_strings":["1Apogee Therapeutics, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apogee Therapeutics, Waltham, MA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034350503","display_name":"Sai P. Thankamony","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sai Thankamony","raw_affiliation_strings":["1Apogee Therapeutics, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apogee Therapeutics, Waltham, MA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112472191","display_name":"Carl L. Dambkowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carl Dambkowski","raw_affiliation_strings":["1Apogee Therapeutics, Waltham, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Apogee Therapeutics, Waltham, MA, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108329364","display_name":"Xiu Qin Lim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiu Qin Lim","raw_affiliation_strings":["2CMAX Clinical Research, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CMAX Clinical Research, Adelaide, Australia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4769","last_page":"PA4769"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.8640000224113464},{"id":"https://openalex.org/keywords/type-2-inflammation","display_name":"type 2 inflammation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/exhaled-nitric-oxide","display_name":"exhaled nitric oxide","score":0.9169999957084656},{"id":"https://openalex.org/keywords/il-13","display_name":"IL-13","score":0.6520000100135803},{"id":"https://openalex.org/keywords/il-4","display_name":"IL-4","score":0.8659999966621399},{"id":"https://openalex.org/keywords/stat6-phosphorylation","display_name":"STAT6 phosphorylation","score":0.9290000200271606},{"id":"https://openalex.org/keywords/ccl17","display_name":"CCL17","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6700000166893005},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.671999990940094},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.5529999732971191},{"id":"https://openalex.org/keywords/airway-inflammation-biomarkers","display_name":"airway inflammation biomarkers","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8910999894142151},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8080000281333923},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.8019999861717224},{"id":"https://openalex.org/C2781142857","wikidata":"https://www.wikidata.org/wiki/Q5420174","display_name":"Exhaled nitric oxide","level":4,"score":0.7383999824523926},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6851999759674072},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6089000105857849},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6008999943733215},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5648999810218811},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5641000270843506},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4950000047683716},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.45730000734329224},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4235999882221222},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41200000047683716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40860000252723694},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3822999894618988},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.3781000077724457},{"id":"https://openalex.org/C105922876","wikidata":"https://www.wikidata.org/wiki/Q1423981","display_name":"Airway","level":2,"score":0.334199994802475},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3244999945163727},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2994000017642975},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.2892000079154968},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.28839999437332153},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.2840999960899353},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.28369998931884766},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.2662000060081482},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.2590999901294708},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.2581999897956848}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa4769","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4769","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4769","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2341287298","https://openalex.org/W7165518039","https://openalex.org/W7154993988","https://openalex.org/W7161555999","https://openalex.org/W2906405080","https://openalex.org/W3215900872","https://openalex.org/W1549472286","https://openalex.org/W4410268764","https://openalex.org/W7161582846","https://openalex.org/W4404104222"],"abstract_inverted_index":{"Introduction:":[0],"APG808":[1,27,35,55,104,135,151,175,202],"is":[2],"a":[3,16,92,194,204,223],"novel":[4],"anti-IL-4R\u03b1":[5,211],"monoclonal":[6],"antibody":[7],"that":[8],"inhibits":[9],"IL-13-":[10],"and":[11,24,31,56,82,112,116,165,180,185],"IL-4-mediated":[12],"signaling.":[13],"Findings":[14],"from":[15,161,170],"first-in-human":[17],"study":[18,75,196],"in":[19,65,138,153,197],"healthy":[20],"volunteers":[21],"demonstrated":[22,203],"safety":[23,50,206],"tolerability":[25],"of":[26,34,51,54,94,129,134,150,156,163,183,187,221,234],"across":[28],"dose":[29],"groups":[30],"optimized":[32,214],"pharmacokinetics":[33],"with":[36,79,140,158,199,209,218,227],"potential":[37],"for":[38],"dosing":[39],"once":[40],"every":[41],"6":[42],"to":[43,101,178],"8":[44],"weeks.":[45],"Aim:":[46],"To":[47],"evaluate":[48],"the":[49,57,210],"multiple":[52,123,132],"doses":[53,133,149],"effect":[58],"on":[59,109],"type":[60],"2":[61],"(T2)":[62],"inflammatory":[63],"biomarkers":[64,119],"asthma.":[66,141],"Methods:":[67],"This":[68],"phase":[69],"1b,":[70],"multiple-dose,":[71],"randomized,":[72],"double-blind,":[73],"proof-of-mechanism":[74],"included":[76],"22":[77],"participants":[78,139,198],"mild-to-moderate":[80,200],"asthma":[81,228],"baseline":[83,162,171],"elevated":[84],"fractional":[85],"exhaled":[86],"nitric":[87],"oxide":[88],"(FeNO;":[89],"\u226525":[90],"ppb),":[91],"marker":[93],"airway":[95],"inflammation.":[96],"Participants":[97],"were":[98,120,136,143],"randomized":[99],"3:1":[100],"receive":[102],"subcutaneous":[103],"600":[105],"mg":[106],"or":[107],"placebo":[108],"days":[110],"1":[111],"29.":[113],"Safety,":[114],"FeNO":[115],"other":[117],"pharmacodynamic":[118],"assessed":[121],"at":[122],"timepoints.":[124],"Results:":[125],"Through":[126],"12":[127],"weeks":[128],"available":[130],"follow-up,":[131],"well-tolerated":[137],"There":[142],"no":[144],"severe":[145],"adverse":[146],"events.":[147],"Multiple":[148],"resulted":[152],"rapid":[154,179],"suppression":[155,182,220],"FeNO,":[157,222],"maximal":[159],"reduction":[160,169,186],"53%,":[164],"maintained":[166],">30":[167],"ppb":[168],"through":[172,189],"week":[173,190],"12.":[174,191],"treatment":[176],"led":[177],"near-complete":[181],"pSTAT6":[184],"TARC":[188],"Conclusion:":[192],"In":[193],"multiple-dose":[195],"asthma,":[201],"favorable":[205],"profile":[207],"consistent":[208],"class.":[212],"The":[213],"PK":[215],"profile,":[216],"together":[217],"durable":[219],"T2":[224],"biomarker":[225],"associated":[226],"exacerbations,":[229],"supports":[230],"continued":[231],"clinical":[232],"development":[233],"APG808.":[235]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}